- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04739982
A Lead-in Study Evaluating Efficacy of GuessWhat Mobile App Therapy for Children With Autism
September 13, 2024 updated by: Dennis Paul Wall, Stanford University
A Lead-in Study Evaluating Mobile Game Based Therapy Among Children With Autism
The following study aims to assess the efficacy, safety data, and best outcome measurements of the mobile game platform, GuessWhat, in delivering behavioral therapy to children with Autism Spectrum Disorder (ASD).
GuessWhat is a mobile application (available for free for iOS and Android) which contains a suite of games: pro-social charades, emotion guessing, and quiz.
Participant families will use their personal smartphones to download the app and play it with their child according to a predetermined regimen.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The following study aims to understand the efficacy and safety of the mobile game platform, GuessWhat, in delivering behavioral therapy to children with Autism Spectrum Disorder (ASD).
GuessWhat is a mobile application (available for free for iOS and Android) which contains a suite of games: pro-social charades, emotion guessing, and quiz.
Participant families will use their personal smartphones to download the app and play it with their child according to a predetermined regimen.
The study will enroll parents who are at least 18 years old and have a child between 3 and 12 years old with a formal ASD diagnosis.
Parents will be asked to complete two clinical outcome measure questionnaires immediately prior to and up to 1 week after playing GuessWhat with their child 3 times per week for 4 weeks.
Study Type
Interventional
Enrollment (Actual)
541
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 12 years (Child)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Parent who is at least 18 years old of child with autism.
- Child with autism is between 3 and 12 years old at time of baseline data collection.
Exclusion Criteria:
- Parent is unable to read English.
- Parent does not have an Android or iOS smartphone compatible with GuessWhat App--the app will be available on Android after further development and we will notify interested families when it becomes available.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment
The GuessWhat app is a charades style game and app that engages parent and child in fluid social interaction where the parent must guess what the child is acting out based on the prompt shown on the phone screen.
Participants will use their own personal phone to download the study app.
Parent and child will be encouraged to play using the emojis and emotion game mode at least 3 individual game sessions per week.
Parents are asked to play GuessWhat with their child 3-4 times per week for 4 weeks.
|
The GuessWhat app is a charades style game and app that engages parent and child in fluid social interaction where the parent must guess what the child is acting out based on the prompt shown on the phone screen.
Participants will use their own personal phone to download the study app.
Parent and child will be encouraged to play using the emojis and emotion game mode at least 3 individual game sessions per week.
Parents are asked to play GuessWhat with their child 3-4 times per week for 4 weeks.
|
|
No Intervention: Treatment as Usual
Participants in control group will continue their treatment as usual.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Parent Reported Socialization Based on the Vineland Adaptive Behavior Scales 3rd Edition (VABS-3) Parent/Caregiver Socialization Subscale, From Baseline to Week 4
Time Frame: Baseline (Week 0), Week 4
|
Vineland Adaptive Behavior Scales, 3rd edition (VABS-3) Socialization subscale of the Parent/Caregiver Comprehensive form will be administered online to the parents.
Scores from the socialization domain of the VABS-III reflects one's functioning in social situations.
The socialization subscale is up to 112 items depending on age and development, where raw scores are converted to IQ-type standard scores with mean 100 and standard deviation of 15, and factor in age equivalents, growth scale values, and higher scores indicate better adaptive functioning.
The range for each subscale is 20 to 140.
|
Baseline (Week 0), Week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Parental Stress Scale - From Baseline to Week 4
Time Frame: Baseline (Week 0), Week 4
|
The Parental Stress Scale is an 18-item parent report scale that evaluates the extent of parent stress.
Scores range from 18-90, where higher scores indicate a higher level of Parental stress.
Parents completed this survey, but were not considered to be enrolled in the study.
|
Baseline (Week 0), Week 4
|
|
GuessWhat App Usage Data
Time Frame: Baseline through week 4 (assessed at week 4)
|
App usage data by participants (children) comprised of number of MojiMatch and Charades Games started.
|
Baseline through week 4 (assessed at week 4)
|
|
Change in Emotion Recognition From Baseline to Week 4
Time Frame: Baseline (Week 0), Week 4
|
Study team used an image based emotion recognition task where participants (children) will select the emotion that corresponds to an emotional facial image in the form of a GIF (Graphics Interchange Format) image.
Participants select 1 of 8 available Ekman emotion labels for 16 facial emotional image stimuli presented in random order.
Correct responses will be measured against a predetermined majority rules consensus of the emotional content of the GIFs.
Scores range from 0 (no emotional image stimuli correctly identified) to 16 (all correctly identified).
|
Baseline (Week 0), Week 4
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
mobile autism risk assessment score at baseline
Time Frame: Baseline (Week 0)
|
Study team will use a level 2 screening tool that has been validated in several studies and that uses a brief parent/caregiver questionnaire with a 2 minute home video to generate a classification score that indicates severity of the autism phenotype (ranging from no autistic symptoms to severe autism) as well as confidence in the classification.
|
Baseline (Week 0)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Dennis P Wall, PhD, Stanford University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 7, 2021
Primary Completion (Actual)
July 15, 2023
Study Completion (Actual)
July 15, 2023
Study Registration Dates
First Submitted
February 1, 2021
First Submitted That Met QC Criteria
February 1, 2021
First Posted (Actual)
February 5, 2021
Study Record Updates
Last Update Posted (Actual)
September 19, 2024
Last Update Submitted That Met QC Criteria
September 13, 2024
Last Verified
September 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 60181
- 5R01LM013364-03 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Time Frame
within 1 year after study completion
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Adia Med of Winter Park LLCRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
Healing Hope InternationalKurve Technology Inc.Enrolling by invitationNeurodevelopmental Disorders | Autism Spectrum Disorder | Autistic Disorder | Autism Spectrum Disorder (ASD) | Autistic Disorders Spectrum | Autism Spectrum Disorder High-Functioning | Autism Spectrum Disorder With Impaired Functional Language | Autistic Disorder of Childhood Onset With Full Syndrome and other conditionsUnited States
Clinical Trials on GuessWhat Mobile App
-
Stanford UniversityCompleted
-
Stanford UniversityNot yet recruitingAutism Spectrum Disorder | AutismUnited States
-
The University of Hong KongNorth District Hospital; Queen Mary Hospital, Hong Kong; Pamela Youde Nethersole... and other collaboratorsUnknownSelf Inflicted Injury | Suicide and Self Inflicted InjuryHong Kong
-
University of ValenciaMinistry of Science and InnovationCompleted
-
University of California, San FranciscoSan Francisco Veterans Affairs Medical CenterCompletedPost Traumatic Stress DisorderUnited States
-
Tan Tock Seng HospitalNanyang Technological University; Geriatric Education and Research InstituteEnrolling by invitationCognitive DeclineSingapore
-
Duke UniversityDuke Institute for Health InnovationCompleted
-
Weill Medical College of Cornell UniversityChildren's Health FundRecruitingDepression | Bipolar Disorder | Anxiety Disorders and Symptoms | SymptomsUnited States
-
University of ZurichSwitzerland: ETH; Switzerland: MakoraCompleted
-
Arizona State UniversityThe University of Texas Health Science Center at San AntonioCompleted